Izotropic Corporation Launches Multilingual Podcast to Educate on Breast Imaging Innovations

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) has taken a significant step towards raising global awareness about the advancements in breast cancer detection technologies with the launch of its multilingual podcast series, Beyond the Mammogram: Rethinking the Future of Breast Imaging. This initiative, available in seven languages, is designed to bridge the information gap for patients, healthcare professionals, and stakeholders by discussing the shortcomings of existing breast imaging tools and introducing the IzoView Breast CT system as a more accurate alternative.

The podcast series repurposes public data into digestible educational content, aiming to foster a deeper understanding of the need for innovation in breast cancer detection. As Izotropic Corporation progresses towards obtaining regulatory approval for its IzoView Breast CT system, the podcast serves as a platform to disseminate valuable information and engage with a global audience. The company's efforts underscore the importance of technological advancements in improving early detection rates and outcomes for breast cancer patients worldwide.

For those interested in learning more about Izotropic Corporation and its pioneering work in breast imaging, additional information can be found by visiting https://izocorp.com or reviewing its profile on SEDAR at https://sedarplus.ca. The latest news and updates regarding Izotropic Corporation are also available in the company’s newsroom at https://ibn.fm/IZOZF.